Priostar® Additives

  • Branched spherical polymers, stable in a wide range of temperatures and pH's.

  • Amine, Hydroxy, and Carboxylate Surfaces.

STARBURST® PAMAM Dendrimers


Printable Catalogs

Priostar® Additives Catalog
PDF(0.3MB)

STARBURST® Catalog
PDF(1.1MB)

 

     
Press Releases

Online ordering of STARBURST® dendrimers now available.
06-25-2008
If you are not automatically redirected to the STARBURST® PAMAM Dendrimer Listing please click First commercial product launch of Starpharma’s DNT Priostar® Dendrimers
- EMD Chemicals Inc. launches DNA Transfection Reagent Kit -

04-22-2008
Melbourne, Australia; 22 April 2008: Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) today announced the first commercial product launch based on its Priostar® dendrimer technology.

The ...

Starpharma signs agreement with Unilever
04-07-2008
Melbourne, Australia; 7 April 2008: Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) today announced the signing of an agreement with Unilever, to co-develop ares ...

New Lower Pricing on STARBURST® PAMAM Dendrimers
02-26-2008
If you are not automatically redirected to the STARBURST® PAMAM Dendrimer Listing please click Oncologix Tech, Inc. and Dendritic Nanotechnologies, Inc. Resolve Leaching Issues with the Oncosphere Product
08-22-2007

Oncologix Tech, Inc. and Dendritic Nanotechnologies, Inc. Resolve Leaching Issues with the Oncosphere Product

Suw ...

DNT to develop water purification technology under US Department of Defense contract
08-02-2007
Mount Pleasant, MI, 2 August, 2007: Dendritic Nanotechnologies Inc (DNT), a subsidiary of Starpharma (ASX: SPL, OTCQX: SPHRY) will use its proprietary technolog ...

Starpharma - Has it found the 'Holy Grail' for siRNA drug developers?
06-12-2007
Bioshares covers Dendritic Nanotechnologies' Priofect™ transfection agent.
Click here for the article.PDF(28KB)


DNT's Priostar™ Dendrimers Significantly Improve Properties of Marketed Fluorescent Reagents
05-07-2007
Mount Pleasant, MI, May 7 /PRNewswire-FirstCall/ -- Dendritic Nanotechnologies Inc (DNT), a subsidiary of Starpharma (ASX: SPL, OTCQX: SPHRY) ...

DNT to supply Dendrimer kits to Sigma-Aldrich
03-23-2007
Melbourne; 23 March, 2007: Starpharma (ASX:SPL, USOTC:SPHRY), through its U.S. subsidiary company Dendritic Nanotechnologies Inc (DNT), will be supplying Sigma-Aldrich with dendrimer kits of tw ...

DNT and EMD Biosciences sign siRNA and DNA reagent license and supply agreement
02-19-2007
Mount Pleasant, MI — 19 February 2007 — Dendritic Nanotechnologies Inc (DNT), a Starpharma Holdings Company(ASX:SPL, USOTC:SPHRY), has entered into a worldwide exclusive license and supply agr ...

Dendritic Nanotechnologies to be Acquired by Australian Nanobiotech Company Starpharma Holdings Ltd.
10-04-2006
Acquisition benefits both companies through a more diversified product pipeline with
near-term revenue opportunities and significant development synergies

Mo ...

Dendritic Nanotechnologies Receives National Cancer Institute Contract to Develop Dendrimer-Based Diagnostic and Therapeutic Delivery System for Ovarian Cancer
09-29-2006
Mount Pleasant, MI—Sept. 29, 2006—Dendritic Nanotechnologies Inc. (DNT) and the National Cancer Institute (NCI) have entered into a Small Business Innovation Re ...

Dendritic Nanotechnologies Announces Initial Roll-Out of New Priostar Dendrimer Family
06-19-2006
DNT’s dendritic polymer nanotechnology offers wide range of applications a ...

Dendritic Nanotechnologies and Lumera Sign Joint Research Agreement
11-10-2005
MOUNT PLEASANT, MI—November 10, 2005—Dendritic Nanotechnologies Inc. (DNT), a company focused on the discovery, development, and commercialization of dendrimer technologies to create a new generatio ...

Dendritic Nanotechnologies’ Priostar Family of Dendrimers Receives “Technology Innovation of the Year” Award
11-09-2005
MOUNT PLEASANT, MI—November 9, 2005—Dendritic Nanotechnologies Inc. (DNT), a company focused on the discovery, development, and commercialization of dendrimer technologies to create a new generatio ...

DENDRITIC NANOTECHNOLOGIES Signs Collaboration Agreement With Nanotechnology Characterization Laboratory
10-10-2005
MOUNT PLEASANT, Mich., Oct. 10 -- DENDRITIC NANOTECHNOLOGIES
INC. (DNT), a company that is focused on the discovery, development, and commercialization of dendrimer technologies to create a new g ...

Dendritic NanoTechnologies Announces New Low-Cost Family of Precision Nanostructures
05-18-2005
DNT’s Priostar dendrimer family broadens potential applications of DNT’s dendritic nanotechnology to a wide range of industries

Dendritic NanoTechnologies Inc. (DNT), a technology compa ...

Dendritic NanoTechnologies Appoints Dow Chemical Licensing Manager to Board of Directors
03-28-2005
Dendritic NanoTechnologies Inc. (DNT), a technology company that is a leading developer and provider of advanced dendritic polymers, or “dendrimers,” today announced it has a ...

Dendritic NanoTechnologies’ Founder to Present Today at FDA Center for Drug Evaluation and Research
03-24-2005
Dr. Tomalia helps FDA scientists better understand nanotechnology and prepare for forthcoming FDA review of nanotechnology-based therapies

Dr. Donald Tomalia, the founder of Dendritic Nano ...

Dendritic NanoTechnologies, Dow and Starpharma Sign Major Three-Way Deal to Commercialize Nanotechnology
01-25-2005
Dow stake positions DNT and Starpharma as leading developers of nanotechnologies for the pharmaceutical, biotechnology industries

Dendritic NanoTechnologies I ...